Jones Financial Companies
OLMA icon

Jones Financial Companies’s Olema Pharmaceuticals OLMA Stock Holding History

Jones Financial Companies’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.3K Buy
3,275
+820
+33% +$11K ﹤0.01% 3242
2026
Q1 		$33.6K Buy
2,455
+1,264
+106% +$28.1K ﹤0.01% 3093
2025
Q4 		$29.8K Buy
+1,191
New +$21.2K ﹤0.01% 2764

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Jones Financial Companies's OLMA Position: Q2 2026 in Review

Jones Financial Companies increased its Olema Pharmaceuticals (OLMA) stake by 33% in Q2 2026, buying an estimated $11K and bringing the position to 3,275 shares worth $37.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3242.

Jones Financial Companies first reported a position in OLMA in Q4 2025 and has held it in 3 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Jones Financial Companies held 3,275 shares of Olema Pharmaceuticals worth $37.3K as of Q2 2026.
  • Jones Financial Companies bought 820 Olema Pharmaceuticals shares in Q2 2026, an estimated $11K.
  • Olema Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3242 holding.
  • Jones Financial Companies first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.